Northern Trust’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-345,352
Closed -$9.67M 4847
2022
Q1
$9.67M Sell
345,352
-12,353
-3% -$339K ﹤0.01% 2163
2021
Q4
$9.77M Sell
357,705
-10,002
-3% -$271K ﹤0.01% 2246
2021
Q3
$10M Sell
367,707
-8,146
-2% -$201K ﹤0.01% 2268
2021
Q2
$6.42M Sell
375,853
-8,274
-2% -$155K ﹤0.01% 2689
2021
Q1
$8.02M Sell
384,127
-34,641
-8% -$799K ﹤0.01% 2442
2020
Q4
$9.59M Sell
418,768
-16,889
-4% -$322K ﹤0.01% 2271
2020
Q3
$7.11M Sell
435,657
-22,283
-5% -$404K ﹤0.01% 2314
2020
Q2
$6.2M Buy
457,940
+27,195
+6% +$316K ﹤0.01% 2385
2020
Q1
$5.1M Buy
430,745
+12,293
+3% +$273K ﹤0.01% 2287
2019
Q4
$10.4M Sell
418,452
-13,311
-3% -$270K ﹤0.01% 2156
2019
Q3
$7.34M Buy
431,763
+23,487
+6% +$428K ﹤0.01% 2331
2019
Q2
$9.29M Buy
408,276
+572
+0.1% +$15.4K ﹤0.01% 2196
2019
Q1
$13.1M Buy
407,704
+5,022
+1% +$155K ﹤0.01% 1971
2018
Q4
$11.3M Sell
402,682
-6,958
-2% -$204K ﹤0.01% 1990
2018
Q3
$11.8M Buy
409,640
+16,846
+4% +$506K ﹤0.01% 2166
2018
Q2
$14.7M Buy
392,794
+37,818
+11% +$1.48M ﹤0.01% 1999
2018
Q1
$14M Buy
354,976
+2,036
+0.6% +$74.4K ﹤0.01% 1941
2017
Q4
$11.4M Sell
352,940
-3,580
-1% -$107K ﹤0.01% 2106
2017
Q3
$11.1M Buy
356,520
+656
+0.2% +$19.4K ﹤0.01% 2136
2017
Q2
$9.95M Buy
355,864
+19,839
+6% +$449K ﹤0.01% 2187
2017
Q1
$5.76M Sell
336,025
-7,968
-2% -$112K ﹤0.01% 2471
2016
Q4
$4.16M Sell
343,993
-15,289
-4% -$198K ﹤0.01% 2662
2016
Q3
$5.69M Buy
359,282
+10,851
+3% +$163K ﹤0.01% 2444
2016
Q2
$4.51M Buy
348,431
+8,705
+3% +$136K ﹤0.01% 2534
2016
Q1
$6.92M Buy
339,726
+8,291
+3% +$150K ﹤0.01% 2208
2015
Q4
$7.46M Buy
331,435
+100,751
+44% +$1.99M ﹤0.01% 2207
2015
Q3
$5.4M Buy
230,684
+114,739
+99% +$3.17M ﹤0.01% 2395
2015
Q2
$3.32M Buy
115,945
+36,855
+47% +$966K ﹤0.01% 2788
2015
Q1
$2.04M Buy
79,090
+85
+0.1% +$1.94K ﹤0.01% 3107
2014
Q4
$1.47M Buy
79,005
+45,537
+136% +$819K ﹤0.01% 3264
2014
Q3
$519K Buy
+33,468
New +$504K ﹤0.01% 3557

Northern Trust's XENT Position: Q2 2022 in Review

Northern Trust sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 345,352 shares — an estimated $9.67M sold.

Northern Trust first reported a position in XENT in Q3 2014 and held it in 31 quarters. The position peaked at $14.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Northern Trust reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Northern Trust sold 345,352 Intersect ENT, Inc shares in Q2 2022, an estimated $9.67M.
  • Northern Trust first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 31 quarters.
  • Northern Trust's Intersect ENT, Inc position peaked at $14.7M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.